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Blood Transfusions and Serum Hepatitis
Richard W. Dunn*
O N MARCH 22, 1966, Look Magazine1 published an article
titled Dirt, Infection, Error and Negligence: The Hidden
Death Threats in Our Hospitals. The effect of this article upon
the public can be likened, but of course to a lesser degree, to
the recent pronouncements of Mr. Ralph Nader 2 on the failure
of the automobile industry to manufacture safe automobiles.
The Look article referred to comments by a Dr. Leon Sussman,
blood specialist at Manhattan's Beth Israel Hospital. Dr. Suss-
man felt that preventable "human failure" in the hospital ac-
counts for at least 50% of blood transfusion accidents.
Blood and Statistics
Injuries and deaths caused by blood transfusions number
in thousands. In 19613 it was statistically noted that about three
and a half million transfusions were administered annually in
the United States. Of those, about three thousand resulted in
death. Of course, with the population growth over the past six
years the number of transfusions could exceed four million per
year. The 1965 statistics on the number of deaths resulting from
negligence in transfusing blood are not known to this writer.
That figure is, however, not significant, since statistics cannot
accurately reflect the number of injuries short of death, which
were the result of negligence before, during, or after a blood
transfusion.
For example, in 1954 Dr. A. S. Weiner estimated that
Homologous Serum Hepatitis results in one out of five hundred
transfusions.4 The death rate from Homologous Serum Hepatitis
is statistically not stabilized since death is more prevalent with
donees over the age of 40, and many times other complications
are involved.
*Of the Cleveland Bar.
1 Look Magazine, March 22, 1966, p. 27.
2 Nader, Unsafe at Any Speed (1965).
3 11 Am. Jur. Proof of Facts, p. 331 (1961).
4 Weiner, Prevention of Accident in Blood Transfusion, 156 J. A. M. A. 1301
(Dec. 4, 1954).
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Medical References
Some definitive articles are available which succinctly state
the problems and complications involved in the medical analysis
and transfusion of blood.5 Similarly, general blood transfusion
problems and the law applicable to each problem area (sensiti-
zation-mistyping-mislabeling-emergency situations-trans-
mission of disease-risks-theories on liability) are represented
in many works."
One of the most troublesome of the transfusion-transmitted
diseases is homologous serum hepatitis (HSH). The crux of the
problem is that the virus of this disease cannot as yet be de-
tected in whole blood. Sole reliance in detecting serum hepatitis
must be placed on the reliability of the donor's history. In the
case of blood plasma, as distinguished from whole blood, the
virus of this disease can be destroyed by storage. 7
The transfusion of whole blood always is a potentially
serious procedure. The "technique" includes pre-transfusion
tests and checks to insure that a safe transfusion will be
properly administered.8
H. S. H. is a form of hepatitis "transmitted by injections of
contaminated blood or blood derivative or merely by a needle,
lancet or other instrument contaminated and not sterilized." 9
It should be noted that H. S. H. can be transmitted through or
from the needle. The only way H. S. H. can be transmitted is by
parenteral routes (through a muscle or vein, or any route other
than the alimentary tract).1o The incubation period of this disease
varies among individuals from 6 weeks to 6 months." So in
those cases where the person receiving contaminated blood con-
tracts the disease following a long incubation period, the trail
5 Hemolytic Transfusion Reactions-Medico legal Aspects, 2 J. of Foreign
Med. 78 (1955).
6 Thoreh, Surgical Errors and Safeguards (J. B. Lippincott Co., 1960);
Thomas, Blood Transfusion Liability, 10 Clev-Mar. L. Rev. 469 (1961); notes,
37 Notre Dame Law. 565 (1962); Liability For Blood Transfusion Injuries, 42
Minn. L. Rev. 640 (1958); For tortious aspects of blood donations and blood
transfusion, see: 59 A. L. R. 2d 768-787; 5 A. L. R. 2d, Later Case Service,
Vol. 5.
7 Bowen, Malpractice Actions Involving Blood Transfusions, 9 Defense L. J.,
45 (1961).
8 Kramer, C., Medical Malpractice, 86 (Practicing Law Inst., rev. ed. 1965).
) Stedman's Medical Dictionary (Unabridged Lawyers Ed., 1961).
10 7 Traumatic Medicine and Surgery for the Attorney, 272-273 (1959).
11 Ibid.
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tends to grow very cold, and with each passing day important
evidentiary matter disappears. In many cases the patient does
not relate his hepatitis problem to past transfusion exposure.
Cases and Holdings
A case of negligence may be proved, but at too late a date
to effect a recovery from the right defendant. In Hidy v. State,
12
the plaintiff died of H. S. H., after a transfusion of unirradiated
war surplus pooled blood plasma. Plaintiff's suit against the
State alleged negligence in that the State failed to irradiate the
plasma, as had been made compulsory by The National Health
Council. In finding for the defendant, the Court conceded that
a warning had been issued concerning pooled plasma and the
dangers extant in using it without irradiation, but said there
was no negligence by the State in its failure to stop distribution
and call in the unused plasma. The Court also indicated that
even if the State had been negligent, there was the independent
intervening agency of the physician, presumably competent, who
directed the administration of the plasma to the plaintiff. The
plaintiff brought a timely action but against the wrong defend-
ant.
It was held in Fisher v. Wilmington Gen'l. Hospital13 that
there was no duty to warn a patient of the risk of contracting
H. S. H. as a result of a transfusion. The Court's rationale was
grounded upon its classification of the known risk as one not
imposing upon defendant a duty to warn of the possibility of
contracting H. S. H. This is one area where the treating phy-
sician is "damned if he does and damned if he doesn't." To
warn a patient of such a danger might affect the patient psy-
chologically and diminish the chance of success.
Blood and Sales Acts
An H. S. H. victim in Tennessee sued the manufacturer of
blood plasma, alleging that the plasma was adulterated and
filthy and in violation of the Tennessee Food, Drug and Cos-
metic Act. 14 In finding for the defendant, the Court said the
12 207 Misc. 207, 137 N. Y. S. 2d 334, affg. 2 App. Div. 644, 151 N. Y. S. 2d
621 (1956).
13 1 Storey (51 Del.) 554, 149 A. 2d 749 (1959).
14 Merck and Co. Inc. v. Kidd, 242 F. 2d 592 (D. C. Tenn. 1957).
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plasma was not a filthy substance because impurity could not
be discerned miscroscopically. Since the virus could not be
seen, could not be described, and its presence could not be de-
tected, it was not a "filthy substance" within the intent of the
statute. When and if research develops techniques of physically
detecting H. S. H., and upon proof of the blood being adulterated,
the Tennessee Courts would appear to be placed in the position
of having to apply their Food, Drug and Cosmetic Act to blood.
In another case the plaintiff based his action for injury
from a blood transfusion on breach of implied warranty, and
relied on the State Sales Act regulating the sale of deleterious
substances not fit for human consumption. The Court said that a
blood transfusion was essentially a service and not a sale, and
that the Sales Act had no application notwithstanding the fact
that the plaintiff was charged $6015 for the transfusion. Other
jurisdictions'0 have similarly held that the monies paid for
blood and blood transfusions are to be construed as service and
not a sale.
Specifically, some states have enacted statutes which pro-
vide that:
... procurement, processing and distribution of blood,
plasma, blood products and blood derivatives for the pur-
pose of injecting or transfusing the same or any of them
into the human body shall be construed to be and is de-
clared to be, for all purposes whatsoever, the rendition of
a service by each and every person, firm or corporation
participating therein, and shall not be construed to be, and
is declared not to be a sale of such whole blood, plasma,
blood products or blood derivatives, for any purpose or
purposes whatsoever. 17
The dissenting opinion in Perlmutter v. Beth David Hos-
pital's is based upon the existence of an implied warranty that
drugs are reasonably fit for human consumption, with no dis-
tinction being made between drugs and blood, at least as a
matter of pleading. The three dissenting judges felt that the
15 Perlmutter v. Beth David Hospital, 308 N. Y. 100, 123 N.E. 2d 792 (1954).
16 Koenig v. Milwaukee Blood Center, Inc., 23 Wis. 2d 324, 127 N.W. 2d 50
(1964); Sloncher v. St. Joseph's Hospital, 233 F. Supp. 105 (D. Colo. 1964);
Whitehurst v. American National Red Cross, 402 P. 2d 584 (Ariz. App.
1965).
17 Calif. Health & Safety Code Sec. 1623 (1955); Ariz. Rev. Stats. § 36-1151,
added, Laws 1964, Ch. 83 § 1.
18 Supra note 15.
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plaintiff should have had the opportunity to present evidence
that there was a sale, rather than having her case dismissed for
insufficiency in stating a cause of action for implied breach of
warranty.
In the vaccine cases, 19 negligence has successfully sounded
in implied warranty. Unfortunately the courts have maintained
an extraordinary and illogical position in transfusion cases by
holding that wholesome blood is no different from blood contain-
ing the H. S. H. virus. This reasoning would be acceptable only
if the courts said that the intended purpose of a blood trans-
fusion is to propagate H. S. H. among transfusees.
Another point worthy of consideration is that the blood
bank or blood distributing agency which sells the blood to the
hospital actually does no more than supply blood for a price,
yet the sale of that blood is construed as a service. This is true
even though the seller or distributor has absolutely no contact
with the ultimate donee. 20 Why should the blood bank or dis-
tributing agency not be held accountable?
When and if a trend starts, whereby plaintiffs begin to ob-
tain awards for damages sustained as a result of negligence in
administration of H. S. H. blood transfusions, the impact on
medicine may be as dramatic as was the decision in Mac Pherson
v. Buick Motor Co. 21 as to manufacturers.
Check List as to Facts
1. Who is the negligent party? (The doctor, the hospital or
a specific hospital employee, the supplier, an individual or
possibly the donor). Consider joinder statutes, so that the
negligent party is not freed by the statute of limitations.
2. What was the transfusion procedure? (both for the
hospital, and hospitals in the community, for the doctors,
nurses and labs). If there was a deviation from normal
procedure, what was the reason for that deviation?
3. Did the donee or donee's family sign a pre-operative or
pre-transfusion release? (Was the release fully explained,
was there an emergency situation, was the risk involved
abnormally great?)
19 Gottsdanker v. Cutter Laboratories, 182 Cal. App. 2d 602, 6 Cal. Rptr. 320(1960).
20 Balkowitsch v. Minneapolis War Memorial Blood Bank, Inc., 270 Minn.
151, 132 N.W. 2d 805 (1965); Goely v. J. K. & Susie L. Wadley Research In-
stitute and Blood Bank, 350 S.W. 2d 573 (Tex. App. 1961).
21 217 N. Y. 382, 111 N.E. 1050 (1916).
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4. Was the alleged negligence the proximate cause of the
donee's death or injury? (Did the donee have a hepatitis
history-would the heart patient have died regardless of
the transfusion-was there some intervening cause?)
5. Can the history of the blood transfused be traced from
the time of the donation to the time of the transfusion?
(Proper storage-contamination-labeling).
6. Is the H. S. H. merely an element of damages caused by
some other event? (Injury caused by negligent third party,
which injury necessitated a transfusion?)
7. Was gamma globulin considered in light of the age and
condition of the patient? Should it have been considered?
It has been reliably demonstrated that, in approximately
three quarters of transfused persons, gamma globulin from
pools of human blood plasma prepared by the ethanol fac-
tionation method has prevented serum hepatitis, . . . In
view of . . . developments and the vital importance of the
problem in persons over 40 years of age, the routine ad-
ministration of gamma globulin after blood transfusion
should be given serious consideration .... 22
8. Was the transfusion necessary? (How much blood was
lost? 500-700 cc. loss of whole blood should be able to be
comfortably tolerated by an adequately prepared patient.) 23
9. What post and pre-operative and post and pre-trans-
fusion procedures were employed? (Were these procedures
in keeping with accepted standards?)
Massachusetts General Hospital, in the attempt to tighten
its controls involving blood transfusions, adheres to an in-
flexible rule in its blood bank; two different technicians use
two different blood-matching techniques on each blood
sample. Also, to reduce chances of transmitting infection,
needles are discarded after one use, as are syringes and
plastic bags.
10. Did the injury or death concur in time with the injury
or death of other patients who received transfusions?
(Either in the same hospital or the same community.)
11. Is the situation such that res ipsa loquitur may be in-
voked? (Was the injury-producing instrumentality within
the exclusive control of the defendant?)
By exhausting the possibilities contained in the above listed
items, counsel should be well on his way towards establishing a
firm foundation for his case.
22 185 A. M. A. Magazine (No. 13), p. 1037, Sept. 28, 1963.
23 "Whole Blood Transfusions in Surgical Patients," 39 Magazine of Sur-
gical Clinics of North America (1) (Feb. 1959).
Sept., 1966
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Proof
Once the foundation has been laid, one must consider the
evidence required and the need to prove each and every allega-
tion. If a question of a physician's malpractice is the point in
issue, one must give thought to obtaining a medical expert who
will testify against the defendant. One may also, but to a lesser
degree, be confronted with the same problem in establishing
the negligence of the hospitals' employees, whereby the negli-
gent act complained of is a deviation from accepted medical
standards in the care and treatment of a patient. A nurse's
judgment, an incorrect technician's analysis, or perhaps some-
thing as minute as hospital house-keeping procedures, are pos-
sible considerations.
Other problem areas also arise which at first blush may
seem insurmountable. In a case where it was alleged that an
unsterile needle was the producing cause of injury, the court
held that plaintiff must show by competent evidence, that the
needle used was, at the time of its use, infected or contaminated,
and that such needle was a proximate cause of the injuries. It
is not enough that the evidence shows that Mrs. Brown's arm
became infected and that she has sustained injuries and dam-
age.2 4 Plaintiff must prove at what time the infection was in-
troduced into her arm.
Consider, then, the tremendous burden in proving that a
needle, tubing, bottle, syringes or any other implement was un-
sterile or contaminated with H. S. H. This evidentiary problem
arises in areas where the medical expert is not required to sub-
stantiate the alleged negligence, but where negligence may be
shown otherwise.
As to infections resulting from blood transfusions, it was
held in Cox v. Saskatoon25 that since there was medical testi-
mony indicating that the infectious source could have been ex-
ternal as well as internal, regardless of that which may have
caused the disease, the plaintiff had not proved his case.
One must specifically isolate the medical issues of the client's
injury, and determine what expert medical testimony can be
based on the medical facts to resolve those issues. This can be
done only by consulting with medical experts. If after this
24 Brown v. Shannon West Texas Memorial Hospital, 222 S.W. 2d 248 (Tex.
Civ. App. 1949).
25 1 West Weekly R., 717, 2 D. L. R. 412 CA (1942).
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consultation, it is determined that the medical issues cannot be
resolved, one must consider the possibility of applying res ipsa
loquitur, or in the alternative, allege a breach of implied war-
ranty. Implied warranty is not well taken by the courts in
transfusion cases, but this would appear to be the weak area
upon which to concentrate.
Procedures employed in transfusions should be closely
scrutinized, and although the trial does not begin in the operating
room, it may well end there. Answers to the following questions
must be secured:
1. Who the donor may have been, and what medical history,
if any was taken? (Was there a standard application form
for taking the donor's history in conformance with accepted
and reasonable procedures? Is the donor or the person who
took the blood available to testify?)
If possible, check with the donor personally to determine
his history, what history was requested, and what were the
physical circumstances surrounding the giving of the blood.
2. How was the blood stored? Where was it stored? Was it
whole blood or plasma? Who had access to the storage area?
What tests were made prior to storage? Who made those
tests?
3. What route did the blood take from the donor to the
donee? (Was there a delay in shipment, or any other cir-
cumstances which could have affected the blood while it
was being transported, and are witnesses able to so testify
available?)
4. Were laboratory tests made at the hospital upon the re-
ceipt of blood? Who made the tests? What were the quali-
fications of the testing person? Who was the authority in
charge of the testing? What testing and labeling procedures
were employed (Labeling, mis-matching?).
5. What were the transfusion techniques employed? Was
there, due to unusual circumstances, a short term or even
a one-time deviation from the normal technique usually em-
ployed?
6. Determine who were involved in the transfusion, and
their qualifications.
7. Are the instruments used in the transfusion available?
Can their ultimate disposition after the transfusion be de-
termined?
8. Were there any verbal admissions against interest, as to
what took place at the time of the transfusion? Is res gestae
applicable? Were records kept and available?
Sept., 1966
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9. Was there, from the time when the blood was first do-
nated to the time when it was transfused, a violation of any
regulation, ordinance, statute, or any other codes or stand-
ards of safety issued or sponsored by governmental bodies or
voluntary associations providing safeguards for the taking,
storage, labeling or the transfusion of whole blood or plasma?
10. Has every discovery tactic been employed to its fullest
extent?
Conclusion
It is readily discernible from the foregoing that successful
litigation of blood transfusion cases is most difficult. This is an
area of the law which, because of its present unacceptable posi-
tion, requires change. The umbrella of protection which the
courts extend to cover the dissemination of deleterious blood and
its classification as a service must be removed. This will only
be achieved by constant litigation of well-prepared cases by
competent men.
9Published by EngagedScholarship@CSU, 1966
